Rchr
J-GLOBAL ID：200901051622325502
Update date: Feb. 14, 2024
Suzuki Shioto
スズキ シオト | Suzuki Shioto
MISC (30)：
Yoh Dobashi, Shioto Suzuki, Hirochika Matsubara, Maiko Kimura, Shunsuke Endo, Akishi Ooi. Critical and Diverse Involvement of Akt/Mammalian Target of Rapamycin Signaling in Human Lung Carcinomas. CANCER. 2009. 115. 1. 107-118
Akishi Ooi, Shioto Suzuki, Kumiko Nakazawa, Jun Itakura, Issei Imoto, Hiroyuki Nakamura, Yoh Dobashi. Gene Amplification of Myc and its Coamplification with ERBB2 and EGFR in Gallbladder Adenocarcinoma. ANTICANCER RESEARCH. 2009. 29. 1. 19-26
Yoh Dobashi, Shioto Suzuki, Hirochika Matsubara, Maiko Kimura, Shunsuke Endo, Akishi Ooi. Critical and Diverse Involvement of Akt/Mammalian Target of Rapamycin Signaling in Human Lung Carcinomas. CANCER. 2009. 115. 1. 107-118
Akishi Ooi, Shioto Suzuki, Kumiko Nakazawa, Jun Itakura, Issei Imoto, Hiroyuki Nakamura, Yoh Dobashi. Gene Amplification of Myc and its Coamplification with ERBB2 and EGFR in Gallbladder Adenocarcinoma. ANTICANCER RESEARCH. 2009. 29. 1. 19-26
Shioto Suzuki, Carl-Henrik Heldin, Rainer Lothar Heuchel. Platelet-derived growth factor receptor-beta, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma. BMC CANCER. 2007. 7. 1. 224
ｍore...
Education (2)：
Kanazawa University
Kanazawa University
Professional career (1)：
Ph.D. (Kanazawa University)
Work history (1)：
Kanazawa University Institute of Medical,Pharmaceutical and Health Sciences, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Faculty of Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
